Caregiver of the Month for March: Thanatcha Cholpradit
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. It's Time to Tell the Stories! Thanatcha Cholpradit shares her story.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. It's Time to Tell the Stories! Thanatcha Cholpradit shares her story.
International access to cancer treatment can be challenging. Access to effective treatment in a time of war provides a an even more daunting challenge.
Join medical professionals and the patient advocacy community on Tuesday, April 26, 2022 for a CME conference, “Rare Cancers: Great Unmet Medical Needs” hosted by Columbia University Herbert Irving Comprehensive Cancer Center and the Jed Ian Taxel Foundation for Rare Cancer Research.
The Life Raft Group welcomes new leadership to the our Board of Directors.
This webinar is the Life Raft Group's presentation in honor of Rare Disease Day. Rare disease day is an observance held on the last day of February to raise awareness for rare diseases and to help improve access to treatment and medical care.
The Life Raft Group welcomes our newest Medical Advisory Board (MAB) member Dr. Neeta Somaiah of The University of Texas MD Anderson Cancer Center.
NCCN’s Dr. Crystal Denlinger and Dottie Shead reviewed general principles of appropriate survivorship care and how to access and understand patient guidelines related to survivorship care.
US GIST Mentor Director, Santy DiSabatino, shares what having a Mentor means to the newly diagnosed and what being a GIST Mentor means to him and he makes an appeal for more volunteers to mentor LRG patients and caregivers.
Lidia Kornienko was searching for answers and when she reached out she found generous people willing to help assist her on the path to mutational testing and an effective treatment plan.
Our feature story is about a couple, Ira & Kay Stolzer, who have supported each other throughout their 41-year marriage and a GIST journey.